We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+38.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$28.8B
Cap. Flow %
-4.24%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,632
Reduced
714
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 18.45%
2 Healthcare 18.09%
3 Consumer Discretionary 13.59%
4 Financials 13.39%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCI
1176
DELISTED
Navigant Consulting, Inc.
NCI
$19.4M ﹤0.01%
995,120
-280,522
-22% -$6.56M
KNX icon
1177
Knight Transportation
KNX
$11.9B
$19.3M ﹤0.01%
590,413
+121,668
+26% +$3.87M
HAS icon
1178
Hasbro
HAS
$13.6B
$19.2M ﹤0.01%
225,587
+6,833
+3% +$595K
IIIN icon
1179
Insteel Industries
IIIN
$634M
$19.2M ﹤0.01%
916,479
+272,610
+42% +$6M
SASR
1180
DELISTED
Sandy Spring Bancorp Inc
SASR
$19.2M ﹤0.01%
612,813
-241,929
-28% -$8M
IFFT
1181
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
$19.2M ﹤0.01%
390,765
-13,564
-3% -$694K
PPC icon
1182
Pilgrim's Pride
PPC
$6.57B
$19.1M ﹤0.01%
858,907
+834,021
+3,351% +$16.4M
GGAL icon
1183
Galicia Financial Group
GGAL
$7.23B
$19M ﹤0.01%
745,656
+98,030
+15% +$3.07M
DEO icon
1184
Diageo
DEO
$52.8B
$19M ﹤0.01%
116,015
-101
-0.1% -$15.4K
PRTY
1185
DELISTED
Party City Holdco Inc.
PRTY
$19M ﹤0.01%
2,387,839
-185,078
-7% -$1.92M
FTI icon
1186
TechnipFMC
FTI
$30.1B
$18.9M ﹤0.01%
1,082,861
-10,109
-0.9% -$171K
SYNH
1187
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$18.9M ﹤0.01%
365,180
+131
+0% +$6.35K
ESPR
1188
DELISTED
Esperion Therapeutics
ESPR
$18.7M ﹤0.01%
465,557
+168,884
+57% +$7.58M
MTG icon
1189
MGIC Investment
MTG
$6.33B
$18.7M ﹤0.01%
1,414,527
-744,327
-34% -$9.27M
JBSS icon
1190
John B. Sanfilippo & Son
JBSS
$1.01B
$18.6M ﹤0.01%
258,732
+152
+0.1% +$10.1K
POLY
1191
DELISTED
Plantronics, Inc.
POLY
$18.6M ﹤0.01%
402,807
-52,142
-11% -$2.28M
GSAH.U
1192
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$18.5M ﹤0.01%
1,765,555
+29,600
+2% +$307K
ABEO icon
1193
Abeona Therapeutics
ABEO
$361M
$18.4M ﹤0.01%
100,134
-1,848
-2% -$330K
JELD icon
1194
JELD-WEN Holding
JELD
$170M
$18.4M ﹤0.01%
1,040,131
+532,495
+105% +$9.58M
NOV icon
1195
NOV
NOV
$7.36B
$18.3M ﹤0.01%
686,980
+71,710
+12% +$2.03M
HCSG icon
1196
Healthcare Services Group
HCSG
$1.45B
$18.3M ﹤0.01%
554,449
-3,143,460
-85% -$120M
INGN icon
1197
Inogen
INGN
$154M
$18.3M ﹤0.01%
191,705
-88,920
-32% -$11.1M
ABEV icon
1198
Ambev
ABEV
$43.8B
$18.3M ﹤0.01%
4,249,200
+1,400
+0% +$6.43K
HONE
1199
DELISTED
HarborOne Bancorp
HONE
$18.2M ﹤0.01%
1,897,862
+6,641
+0.4% +$59.7K
CBUS icon
1200
Cibus
CBUS
$145M
$18.2M ﹤0.01%
20,674
-1,219
-6% -$869K

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.